Related Experiment Video
Updated: Apr 14, 2026
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.6K
Integration of Pharmacists' Knowledge into a Predictive Model for Teicoplanin Dose Planning
Tetsuo Matsuzaki1, Tsuyoshi Nakai2, Yoshiaki Kato1
1Hospital Pharmacy, Nagoya University Hospital, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan.
Biological & Pharmaceutical Bulletin
|April 12, 2026
Summary
Machine learning (ML) models can assist in planning initial teicoplanin doses, improving therapeutic drug monitoring (TDM) for methicillin-resistant Staphylococcus aureus infections. This approach integrates clinical expertise to optimize antibiotic dosing strategies.
Area of Science:
- Pharmacology
- Infectious Diseases
- Artificial Intelligence
Background:
- Teicoplanin is crucial for treating methicillin-resistant Staphylococcus aureus (MRSA) infections.
- Therapeutic drug monitoring (TDM) of teicoplanin trough concentrations is vital for efficacy and safety.
- Initial teicoplanin dosing requires significant clinician expertise.
Purpose of the Study:
- To develop a machine learning (ML) model for predicting initial teicoplanin doses.
- To integrate clinician expertise into an automated dose planning system.
- To support optimal teicoplanin treatment strategies.
Main Methods:
- Trained an ML model using initial teicoplanin dose plans from TDM pharmacists.
- Validated the model's ability to emulate expert dosing decisions.
- Confirmed improved early therapeutic target attainment with TDM pharmacist-led dosing.
Main Results:
- TDM pharmacist-led dosing significantly improved early therapeutic target attainment in non-ICU patients.
- The ML model achieved modest prediction accuracies (45.8% for loading, 66.7% for maintenance doses).
- The model demonstrated successful learning of basic teicoplanin dose planning policies.
Conclusions:
- ML approaches show potential for supporting appropriate initial teicoplanin dosing.
- Integrating clinical expertise via ML can aid in optimizing antibiotic therapy.
- Further development of ML models may enhance TDM pharmacist decision-making.
Related Concept Videos
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
101
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
101
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
85
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
85
01:14Pharmacokinetic–Pharmacodynamic Relationship: Model Components
175
Pharmacokinetic-pharmacodynamic (PK–PD) modeling is essential in drug development and clinical pharmacology. It provides a quantitative framework to predict drug behavior and response over time. This approach integrates pharmacokinetics (PK), which describes the drug's absorption, distribution, metabolism, and excretion, with pharmacodynamics (PD), which characterizes the drug’s biological effects and mechanisms of action.The disposition kinetics of a drug determine its plasma...
175
01:26Pharmacokinetic Models: Comparison and Selection Criterion
464
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
464
01:20Pharmacokinetic Models: Overview
2.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.8K
01:27Pharmacodynamic Models: Overview
126
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
126